S. Nordeen

发表

Luciferase reporter gene vectors for analysis of promoters and enhancers.

S. Nordeen, S K Nordeen, 1988, BioTechniques.

Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A.

D. Edwards, S. Nordeen, D. Toft, 1995, Molecular endocrinology.

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

S. Nordeen, E. Howe, D. Cochrane, 2009, Molecular Cancer Therapeutics.

A New Small Molecule Inhibitor of Estrogen Receptor α Binding to Estrogen Response Elements Blocks Estrogen-dependent Growth of Cancer Cells*

Jingwei Cheng, E. Wilson, A. Nardulli, 2008, Journal of Biological Chemistry.

Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation*

S. Nordeen, D. Leung, E. Goleva, 2009, The Journal of Biological Chemistry.

The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.

S. Nordeen, M. Moyer, T. Archer, 1994, Molecular endocrinology.

In Vitro Fluorescence Anisotropy Analysis of the Interaction of Full-length SRC1a with Estrogen Receptors α and β Supports an Active Displacement Model for Coregulator Utilization*

S. Nordeen, D. J. Shapiro, Chen Zhang, 2007, Journal of Biological Chemistry.

Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines

M. Lucia, M. Varella‐Garcia, G. Miller, 2003, The Prostate.

Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53‐dependent mechanism and inhibition of prostate cancer cell growth

M. Lucia, S. Baek, T. Eling, 2006, Journal of cellular physiology.

Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions.

S. Nordeen, D. J. Shapiro, Stanley Wang, 2004, BioTechniques.

Differential gene induction by glucocorticoid and progesterone receptors

S. Nordeen, V. G. Thackray, B. Lieberman, 1998, The Journal of Steroid Biochemistry and Molecular Biology.

Molecular characterization of human prostate carcinoma cell lines

C. Korch, M. Lucia, M. Varella‐Garcia, 2003, The Prostate.

The cyclin B2 component of MPF is a substrate for the c-mosxe proto-oncogene product

J. Maller, J. Gautier, S. Nordeen, 1990, Cell.

Endocrine Disrupting Activities of the Flavonoid Nutraceuticals Luteolin and Quercetin

S. Nordeen, David N M Jones, T. Jackson, 2013, Hormones and Cancer.

A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase.

D. Fowlkes, S. Nordeen, P. P. Green, 1987, DNA.

Extreme position dependence of a canonical hormone response element.

S. Nordeen, C. A. Ogden, B. Lieberman, 1998, Molecular endocrinology.

Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro

S. Nordeen, L. Ogden, A. Bokhoven, 2006, The Prostate.

Studies of the Mechanism of Glucocorticoid Hormone Action

P. Kollman, M. Karin, J. Baxter, 1983 .

Human progesterone receptor binding to mouse mammary tumor virus deoxyribonucleic acid: dependence on hormone and nonreceptor nuclear factor(s).

D. Edwards, S. Nordeen, P. Estes, 1989, Molecular endocrinology.

Steroid-selective Initiation of Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Is Controlled by the Site of Promoter Integration*

S. Nordeen, J. Lambert, 1998, The Journal of Biological Chemistry.

Evaluations of wasted mouse fibroblasts and SV-40 transformed human fibroblasts as models of ataxia telangiectasia in vitro.

C. Hutchison, M. Edgell, S. Nordeen, 1984, Mutation research.

The two faces of a steroid antagonist: When an antagonist isn't

D. Edwards, D. DeFranco, S. Nordeen, 1995, Steroids.

Modulation of glucocorticoid-regulated transcription by purines: novel characteristics and implications for tissue specificity of steroid responses.

S. Nordeen, M. Moyer, B. J. Bona, 1995, Endocrinology.

Myocardial gene reprogramming associated with a cardiac cross-resistant state induced by LPS preconditioning.

A. Harken, S. Nordeen, Xianzhong Meng, 1998, American journal of physiology. Cell physiology.

Mapping contacts between unpurified human progesterone receptor and the hormone response element of mouse mammary tumor virus.

D. Edwards, S. Nordeen, D. El-Ashry, 1989, DNA.

Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats.

W. Franklin, A. Harken, S. Nordeen, 1996, The American journal of physiology.

Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation.

D. DeFranco, S. Nordeen, M. Moyer, 1993, The Journal of biological chemistry.

8-Alkylthio-6-thio-substituted theophylline analogues as selective noncompetitive progesterone receptor antagonists

E. Wilson, S. Nordeen, D. J. Shapiro, 2012, Steroids.

Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network

S. Nordeen, R. Evans, A. Sarría, 1990, The Journal of cell biology.

Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways

J. Maller, S. Nordeen, F. A. van der Hoorn, 1990, Molecular and cellular biology.

Ha-rasval.l2,Thr-59 Activates S6 Kinase and p34cdc2 Kinase in Xenopus Oocytes: Evidence for c_mosxe-Dependent and -Independent Pathways

Hoorn, J. Minshull, S. Nordeen, 2022 .

Analysis of steroid hormone-induced histone acetylation by chromatin immunoprecipitation assay.

S. Nordeen, J. Lambert, 2001, Methods in molecular biology.

The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.

D. Edwards, S. Nordeen, N. Weigel, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Estrogen agonist and antagonist action on the human estrogen receptor in Drosophila.

S. Nordeen, J. Hooper, V. Thackray, 2000, Endocrinology.

Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A.

S. Nordeen, M. Moyer, B. J. Bona, 1993, Molecular endocrinology.

The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.

D. Edwards, S. Nordeen, C. Muro-Cacho, 1993, Endocrinology.

Effects of fasting and insulin administration on polyribosome formation in rat epididymal fat cells.

S. Nordeen, R. T. Lyons, D. Young, 1980, The Journal of biological chemistry.

Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

James R Lambert, M. Lucia, P. Werahera, 2003, Cancer research.

DNA Intersegment Transfer, How Steroid Receptors Search for A Target Site*

S. Nordeen, B. Lieberman, 1997, The Journal of Biological Chemistry.

Photoaffinity labeling of glucocorticoid receptors.

J. Baxter, S. Nordeen, N. Lan, 1981, The Journal of biological chemistry.

Glucocorticoid action on rat thymic lymphocytes

S. Nordeen, D. Young, 1976 .

Glucocorticoid action on rat thymic lymphocytes. Experiments utilizing adenosine to support cellular metabolism lead to a reassessment of catabolic hormone actions.

S. Nordeen, D. Young, 1976, The Journal of biological chemistry.

Separation of effects of adenosine on energy metabolism from those on cyclic AMP in rat thymic lymphocytes.

S. Nordeen, D. Young, 1977, The Journal of biological chemistry.

A complete library of point substitution mutations in the glucocorticoid response element of mouse mammary tumor virus.

C. Hutchison, M. Edgell, S. Nordeen, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Photoaffinity labeling of human thyroxine-binding prealbumin with thyroxine and N-(ethyl-2-diazomalonyl)thyroxine.

N. Eberhardt, S. Nordeen, R. Somack, 1982, Biochemistry.

CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins.

S. Nordeen, J. Lambert, 2003, Molecular endocrinology.

A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line.

D. Edwards, S. Nordeen, J. Lawler-Heavner, 1989, Molecular endocrinology.

Overlapping but distinct profiles of gene expression elicited by glucocorticoids and progestins.

Y. Wan, S. Nordeen, 2003, Recent progress in hormone research.

Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells.

Y. Wan, S. Nordeen, 2002, Molecular endocrinology.

A new rat gene RT7 is specifically expressed during spermatogenesis.

S. Nordeen, F. A. Hoorn, F. A. van der Hoorn, 1990, Developmental biology.

The presence or absence of a vimentin-type intermediate filament network affects the shape of the nucleus in human SW-13 cells.

S. Nordeen, J. Lieber, R. Evans, 1994, Journal of cell science.

Identification of genes differentially regulated by glucocorticoids and progestins using a Cre/loxP-mediated retroviral promoter-trapping strategy.

Y. Wan, S. Nordeen, Yihong Wan, 2002, Journal of molecular endocrinology.

The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.

D. Edwards, S. Nordeen, S. Leonhardt, 1998, Endocrinology.

Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form.

D. Edwards, S. Nordeen, D. El-Ashry, 1989, Molecular endocrinology.

Structural determinants of a glucocorticoid receptor recognition element.

C. Hutchison, S. Nordeen, B. Kühnel, 1990, Molecular endocrinology.

Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer

A. van Bokhoven, S. Nordeen, T. Flaig, 2021, Life.

HOXC8 Inhibits Androgen Receptor Signaling in Human Prostate Cancer Cells by Inhibiting SRC-3 Recruitment to Direct Androgen Target Genes

S. Nordeen, S. Axlund, J. Lambert, 2010, Molecular Cancer Research.

Signaling and Regulation HOXC 8 Inhibits Androgen Receptor Signaling in Human Prostate Cancer Cells by Inhibiting SRC-3 Recruitment to Direct Androgen Target Genes

S. Nordeen, S. Axlund, J. Lambert, 2010 .

The constitution of a progesterone response element.

D. Edwards, S. Nordeen, S K Nordeen, 1993, Molecular endocrinology.

Insertion of CTCF-binding sites into a first-generation adenovirus vector reduces the innate inflammatory response and prolongs transgene expression.

S. Nordeen, J. Shao, L. Qiao, 2011, Virology.

Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells

C. Sartorius, S. Nordeen, D. LaBarbera, 2017, Oncogene.

Evidence that heat shock protein-70 associated with progesterone receptors is not involved in receptor-DNA binding.

D. Edwards, W. Welch, S. Nordeen, 1991, Molecular endocrinology.

Mechanisms controlling steroid receptor binding to specific DNA sequences

D. Edwards, A. DeMarzo, S. Nordeen, 1991, Steroids.

High-Mobility Group Chromatin Proteins 1 and 2 Functionally Interact with Steroid Hormone Receptors To Enhance Their DNA Binding In Vitro and Transcriptional Activity in Mammalian Cells

D. Edwards, M. Bianchi, P. Prendergast, 1998, Molecular and Cellular Biology.

Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300

G. Chrousos, S. Nordeen, T. Kino, 1999, The Journal of Steroid Biochemistry and Molecular Biology.

A Noncompetitive Small Molecule Inhibitor of Estrogen-regulated Gene Expression and Breast Cancer Cell Growth That Enhances Proteasome-dependent Degradation of Estrogen Receptor α*

R. Schiff, E. Wilson, S. Nordeen, 2010, The Journal of Biological Chemistry.

Concerted stimulation of transcription by glucocorticoid receptors and basal transcription factors: limited transcriptional synergism suggests mediation by coactivators/adaptors.

S. Nordeen, L. S. Bastian, 1991, Molecular endocrinology.

Transcriptional Analysis of Chromatin Assembled with Purified ACF and dNAP1 Reveals That Acetyl-CoA Is Required for Preinitiation Complex Assembly*

J. T. Kadonaga, S. Nordeen, Wen-rui Jiang, 2000, The Journal of Biological Chemistry.

Novel activation step required for transcriptional competence of progesterone receptor on chromatin templates.

S. Nordeen, D. Toft, V. Thackray, 2003, Molecular endocrinology.

A Composite Enhancer Element Directing Tissue-specific Expression of Mouse Mammary Tumor Virus Requires both Ubiquitous and Tissue-restricted Factors*

S. Nordeen, S. Grimm, 1999, The Journal of Biological Chemistry.

Mouse Mammary Tumor Virus Sequences Responsible for Activating Cellular Oncogenes

S. Nordeen, S. Grimm, 1998, Journal of Virology.

Cloning, sequencing and proposed structure for a prostaglandin F2α receptor regulatory protein

S. Nordeen, D. Orlicky, 1996 .

Human progesterone A-receptors can be synthesized intracellularly and are biologically functional.

K. Horwitz, S. Nordeen, N. Krett, 1988, Biochemical and biophysical research communications.

An enhancer in the c-mos locus binds a nuclear factor 1-like protein.

S. Nordeen, F. A. van der Hoorn, 1989, Biochemical and biophysical research communications.

Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor.

Y. Wan, S. Nordeen, P. R. Housley, 2001, Molecular endocrinology.

Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system.

D. Edwards, A. DeMarzo, S. Nordeen, 1991, Molecular endocrinology.

Modulators of cellular protein phosphorylation alter thetrans-activation function of human progesterone receptor and the biological activity of progesterone antagonists

D. Edwards, S. Nordeen, N. Weigel, 2004, Breast Cancer Research and Treatment.

Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.

M. Lucia, S. Nordeen, T. Flaig, 2007, The Journal of urology.

The coupling of multiple signal transduction pathways with steroid response mechanisms.

S. Nordeen, M. Moyer, B. J. Bona, 1994, Endocrinology.

Application of green fluorescent protein to the study of dynamic protein-protein interactions and subcellular trafficking of steroid receptors.

Y. Wan, S. Nordeen, R. Day, 2001, Methods in molecular biology.

Visualizing protein-protein interactions in the nucleus of the living cell.

Richard N. Day, Y. Wan, S. Nordeen, 1999, Molecular Endocrinology.

Antiprogestins Mediate Differential Effects on Glucocorticoid Receptor Remodeling of Chromatin Structure*

S. Nordeen, T. Archer, C. Fryer, 1998, The Journal of Biological Chemistry.

High-yield purification of functional, full-length steroid receptor coactivator 1 expressed in insect cells.

S. Nordeen, V. Thackray, 2002, BioTechniques.

Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors.

S. Nordeen, Chen Zhang, D. Shapiro, 2013, Methods in molecular biology.

Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.

Y. Wan, J. Baxter, S. Nordeen, 2000, Molecular endocrinology.

Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo.

D. Edwards, W. Welch, S. Nordeen, 1992, Biochemistry.

Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.

D. Edwards, A. DeMarzo, S. Nordeen, 1992, Biochemistry.

Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors

M. Neville, D. Medina, S. Nordeen, 2005, Breast Cancer Research.

Refractoriness of the cyclic AMP response to adenosine and prostaglandin E1 in thymic lymphocytes. Dependence on protein synthesis and energy-providing substrates.

S. Nordeen, D. Young, 1978, The Journal of biological chemistry.

A role for the non-conserved N-terminal domain of the TATA-binding protein in the crosstalk between cell signaling pathways and steroid receptors

S. Nordeen, J. Lambert, 2015 .

Luciferase reporter gene vectors that lack potential AP-1 sites.

S. Nordeen, S. Grimm, 1999, BioTechniques.

Biochemical endpoints of glucocorticoid hormone action

S. Nordeen, R. T. Lyons, D. Young, 1978 .

The Prostate 57 : 205 ^ 225 ( 2003 ) MolecularCharacterizationofHumanProstate CarcinomaCell Lines

C. Korch, M. Lucia, G. Miller, 2003 .

Cloning, sequencing and proposed structure for a prostaglandin F2 alpha receptor regulatory protein.

S. Nordeen, D. Orlicky, 1996, Prostaglandins, Leukotrienes and Essential Fatty Acids.

Visualizing protein-protein interactions in the nucleus of the living cell.

Richard N. Day, Y. Wan, S. Nordeen, 1999, Molecular endocrinology.

A New Small Molecule Inhibitor of Estrogen Receptor α Binding to Estrogen Response Elements Blocks Estrogen-dependent Growth of Cancer Cells*

Jingwei Cheng, E. Wilson, A. Nardulli, 2008, Journal of Biological Chemistry.

HOXC8 Inhibits Androgen Receptor Signaling in Human Prostate Cancer Cells by Inhibiting SRC-3 Recruitment to Direct Androgen Target Genes

S. Nordeen, S. Axlund, J. Lambert, 2010, Molecular Cancer Research.

Activates S6Kinase andp34cdc2 Kinase in XenopusOocytes: Evidence forc_mosxe-Dependent and-Independent Pathways

S. Nordeen, C. Barrett, F. D. Hoorn, 1990 .